UK CBD brand TRIP has received a $12 million investment that will support its continued growth in the United States and across the globe.
Known in the UK as the "Queen's CBD," having received the royal seal of approval by selling out of the Queen's Windsor shop, TRIP was founded by husband-and-wife team Daniel Khoury and Olivia Ferdi after meeting at Cambridge University. The duo launched TRIP after using CBD helped Khoury recover from an accident that required knee surgery just before their wedding. Amazed by CBD's benefits, the two left their careers in law and finance to launch TRIP together and designed an award-winning range of drinks, oils and gummies.
Since the company's launch in 2019, it has dominated the CBD space in the UK, with 88% market share and distribution in over 11,000 retail locations. With a dedicated community of consumers, TRIP sets its sights on the global wellbeing landscape, expanding its retail footprint through strategic partnerships in the United States as Soho House & Co.'s exclusive global CBD supplier and in Los Angeles-based retailer Erewhon.
"Over the last few years the world's attitude towards the importance of mental health has changed dramatically,” Ferdi said. “Since discovering the power of CBD through an incredible personal experience, our mission has always been to share calm in the everyday chaos, with next-generation wellbeing products to power your lifestyle and help care for your mental health. Helping to open up conversations around stress and anxiety, we're excited to create a community across the globe, harnessing the power of plants to find their calm."